viral infection – Page 266 – Communicable Diseases Research

Time Course and Cellular Localization of SARS-CoV Nucleoprotein and RNA in Lungs from Fatal Cases of SARS

Research Article

Published on 2006-02-032022-10-29
Journal: PLoS Medicine
[Category] Coronavirus, MERS,

[키워드] 2003 acute respiratory syndrome alveolar alveolar epithelium antiviral therapy appear assay association Autopsy Canada case cellular China Clinical course clinical disease collected compared coronavirus detected died disease etiological Evidence finding Hong Kong humans illness onset immunohistochemistry In situ Infected involved knowledge less Localization lung lung tissue Lungs Macrophage macrophages monoclonal antibody nucleoprotein outbreak Pathogenesis Patient patients with SARS pneumocyte Pulmonary pathology Region Replication RNA SARS Coronavirus SARS-CoV Seven symptom onset target the disease time Toronto Treatment viral infection virus widespread
[DOI] 10.1371/journal.pmed.0030027 PMC 바로가기 [Article Type] Research Article

The Severe Acute Respiratory Syndrome (SARS)-coronavirus 3a protein may function as a modulator of the trafficking properties of the spike protein

Hypothesis

Published on 2005-02-102022-10-28
Journal: Virology Journal
[Category] Coronavirus,

Severe acute respiratory syndrome (SARS)—paradigm of an emerging viral infection ☆

Article

Published on 2003-11-262022-11-01
Journal: Journal of Clinical Virology
[Category] Coronavirus,

[키워드] 2003 acute respiratory syndrome After Antiviral compound Antiviral treatment approach approaches carried caused China Complete consequence coronavirus country criteria deaths diagnostic test different East effort emerging infection epidemiological Epidemiology Evidence example found Genome globe group Human inactivation Infectious disease International Laboratory laboratory diagnosis molecular virology outbreak Research RNA SARS patients SARS-associated coronavirus (SARS-CoV) SARS-CoV sequenced severe Severe acute respiratory syndrome (SARS) severe respiratory illness spread to stability starting Transmission Vaccine viral infection virus WHO World Health Organization World Health Organization (WHO)
[DOI] 10.1016/j.jcv.2003.09.011 PMC 바로가기 [Article Type] Article